The first point is what most insulin pump users and diabetes healthcare professionals have experienced in practice: that in conditions where blood glucose levels are low–normal at the start of exercise, reducing basal insulin delivery (even by 50%) does not always mitigate against hypoglycaemia. The gene discussed is INS; the disease is diabetes mellitus.